EDA
The article highlights the key points related to the regulatory framework for clinical trials in Egypt.
EDA
The article describes in detail the matters related to the objectives of clinical trials, as well as the applicable regulatory oversight.
EDA
The new article outlines the key points to be addressed when initiating a clinical investigation, as well as upon its completion.
EDA
The new article provides additional clarifications regarding various specific aspects to be taken into consideration by the parties responsible for clinical investigations intended to be conducted in Egypt.
EDA
The new article provides additional clarifications regarding specific aspects associated with recalls, such as appeals to relevant decisions or disposal for medical products.
EDA
The new article pays special attention to the classification of recall actions taken in order to ensure the continuous safety of medical devices allowed for marketing and use in the country.
RegDesk is recognized as a Regulatory Intelligence Representative Vendor! Learn more by reading the 2024 Gartner® Market Guide for Regulatory Intelligence Solutions.
Get the report
